Amgen Inc. Increase (Decrease) in Income Taxes Payable
Amgen Inc. (AMGN) reported Increase (Decrease) in Income Taxes Payable of -$60.00 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable · last filed 2026-08-05
- Amgen Inc. increase (decrease) in income taxes payable for the quarter ending 2026-06-30 was -$131.00M.
- Amgen Inc. increase (decrease) in income taxes payable for the quarter ending 2026-03-31 was $71.00M, a 31.73% decline year-over-year.
- Amgen Inc. increase (decrease) in income taxes payable for the quarter ending 2025-12-31 was -$365.00M, a 788.68% decline year-over-year.
- Amgen Inc. increase (decrease) in income taxes payable for the quarter ending 2025-09-30 was $610.00M, a 146.96% increase year-over-year.
- Amgen Inc. increase (decrease) in income taxes payable for fiscal 2025 was -$2.07B.
- Amgen Inc. increase (decrease) in income taxes payable for fiscal 2024 was -$1.01B.
- Amgen Inc. increase (decrease) in income taxes payable for fiscal 2023 was -$1.03B.
- Amgen Inc. increase (decrease) in income taxes payable for fiscal 2022 was -$647.00M.
| Period end | Increase (Decrease) in Income Taxes Payable 3 month | Increase (Decrease) in Income Taxes Payable 6 month | Increase (Decrease) in Income Taxes Payable 9 month | Increase (Decrease) in Income Taxes Payable 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$131.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | -$60.00M 10-Q · filed 2026-08-05 | -$425.00M derived: sum of 3 quarters · filed 2026-08-05 | $185.00M derived: sum of 4 quarters · filed 2026-08-05 |
| 2026-03-31 | $71.00M 10-Q · filed 2026-05-01 | -$294.00M derived: sum of 2 quarters · filed 2026-05-01 | $316.00M derived: sum of 3 quarters · filed 2026-05-01 | -$2.10B derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-12-31 | -$365.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-13 | $245.00M derived: sum of 2 quarters · filed 2026-02-13 | -$2.17B derived: sum of 3 quarters · filed 2026-08-05 | -$2.07B 10-K · filed 2026-02-13 |
| 2025-09-30 | $610.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | -$1.81B derived: sum of 2 quarters · filed 2026-08-05 | -$1.70B 10-Q · filed 2025-11-05 | -$1.65B derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-06-30 | -$2.42B derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | -$2.31B 10-Q · filed 2026-08-05 | -$2.26B derived: sum of 3 quarters · filed 2026-08-05 | -$2.01B derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-03-31 | $104.00M 10-Q · filed 2026-05-01 | $157.00M derived: sum of 2 quarters · filed 2026-05-01 | $404.00M derived: sum of 3 quarters · filed 2026-05-01 | -$1.13B derived: sum of 4 quarters · filed 2026-05-01 |
| 2024-12-31 | $53.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-13 | $300.00M derived: sum of 2 quarters · filed 2026-02-13 | -$1.23B derived: sum of 3 quarters · filed 2026-02-13 | -$1.01B 10-K · filed 2026-02-13 |
| 2024-09-30 | $247.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | -$1.29B derived: sum of 2 quarters · filed 2025-11-05 | -$1.06B 10-Q · filed 2025-11-05 | -$3.09B derived: sum of 4 quarters · filed 2026-02-13 |
| 2024-06-30 | -$1.53B derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-06 | -$1.31B 10-Q · filed 2025-08-06 | -$3.34B derived: sum of 3 quarters · filed 2026-02-13 | -$2.81B derived: sum of 4 quarters · filed 2026-02-13 |
| 2024-03-31 | $223.00M 10-Q · filed 2025-05-02 | -$1.81B derived: sum of 2 quarters · filed 2026-02-13 | -$1.28B derived: sum of 3 quarters · filed 2026-02-13 | -$1.25B derived: sum of 4 quarters · filed 2026-02-13 |
| 2023-12-31 | -$2.03B derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-13 | -$1.50B derived: sum of 2 quarters · filed 2026-02-13 | -$1.47B derived: sum of 3 quarters · filed 2026-02-13 | -$1.03B 10-K · filed 2026-02-13 |
| 2023-09-30 | $527.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-10-31 | $555.00M derived: sum of 2 quarters · filed 2024-10-31 | $998.00M 10-Q · filed 2024-10-31 | $843.00M derived: sum of 4 quarters · filed 2025-02-14 |
| 2023-06-30 | $28.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-07 | $471.00M 10-Q · filed 2024-08-07 | $316.00M derived: sum of 3 quarters · filed 2025-02-14 | $509.00M derived: sum of 4 quarters · filed 2025-02-14 |
| 2023-03-31 | $443.00M 10-Q · filed 2024-05-03 | $288.00M derived: sum of 2 quarters · filed 2025-02-14 | $481.00M derived: sum of 3 quarters · filed 2025-02-14 | -$522.00M derived: sum of 4 quarters · filed 2025-02-14 |
| 2022-12-31 | -$155.00M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-14 | $38.00M derived: sum of 2 quarters · filed 2025-02-14 | -$965.00M derived: sum of 3 quarters · filed 2025-02-14 | -$647.00M 10-K · filed 2025-02-14 |
| 2022-09-30 | $193.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-10-31 | -$810.00M derived: sum of 2 quarters · filed 2023-10-31 | -$492.00M 10-Q · filed 2023-10-31 | -$627.00M derived: sum of 4 quarters · filed 2024-02-14 |
| 2022-06-30 | -$1.00B derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-04 | -$685.00M 10-Q · filed 2023-08-04 | -$820.00M derived: sum of 3 quarters · filed 2024-02-14 | -$609.00M derived: sum of 4 quarters · filed 2024-02-14 |
| 2022-03-31 | $318.00M 10-Q · filed 2023-04-28 | $183.00M derived: sum of 2 quarters · filed 2024-02-14 | $394.00M derived: sum of 3 quarters · filed 2024-02-14 | -$588.00M derived: sum of 4 quarters · filed 2024-02-14 |
| 2021-12-31 | -$135.00M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-14 | $76.00M derived: sum of 2 quarters · filed 2024-02-14 | -$906.00M derived: sum of 3 quarters · filed 2024-02-14 | -$854.00M 10-K · filed 2024-02-14 |
| 2021-09-30 | $211.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-04 | -$771.00M derived: sum of 2 quarters · filed 2022-11-04 | -$719.00M 10-Q · filed 2022-11-04 | -$667.00M derived: sum of 4 quarters · filed 2023-02-09 |
| 2021-06-30 | -$982.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-05 | -$930.00M 10-Q · filed 2022-08-05 | -$878.00M derived: sum of 3 quarters · filed 2023-02-09 | -$1.63B derived: sum of 4 quarters · filed 2023-02-09 |
| 2021-03-31 | $52.00M 10-Q · filed 2022-04-28 | $104.00M derived: sum of 2 quarters · filed 2023-02-09 | -$649.00M derived: sum of 3 quarters · filed 2023-02-09 | -$334.00M derived: sum of 4 quarters · filed 2023-02-09 |
| 2020-12-31 | $52.00M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-09 | -$701.00M derived: sum of 2 quarters · filed 2023-02-09 | -$386.00M derived: sum of 3 quarters · filed 2023-02-09 | -$249.00M 10-K · filed 2023-02-09 |
| 2020-09-30 | -$753.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-03 | -$438.00M derived: sum of 2 quarters · filed 2021-11-03 | -$301.00M 10-Q · filed 2021-11-03 | -$758.00M derived: sum of 4 quarters · filed 2022-02-16 |
| 2020-06-30 | $315.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-04 | $452.00M 10-Q · filed 2021-08-04 | -$5.00M derived: sum of 3 quarters · filed 2022-02-16 | $124.00M derived: sum of 4 quarters · filed 2022-02-16 |
| 2020-03-31 | $137.00M 10-Q · filed 2021-04-28 | -$320.00M derived: sum of 2 quarters · filed 2022-02-16 | -$191.00M derived: sum of 3 quarters · filed 2022-02-16 | -$725.00M derived: sum of 4 quarters · filed 2022-02-16 |
| 2019-12-31 | -$457.00M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-16 | -$328.00M derived: sum of 2 quarters · filed 2022-02-16 | -$862.00M derived: sum of 3 quarters · filed 2022-02-16 | -$585.00M 10-K · filed 2022-02-16 |
| 2019-09-30 | $129.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-10-29 | -$405.00M derived: sum of 2 quarters · filed 2020-10-29 | -$128.00M 10-Q · filed 2020-10-29 | -$105.00M derived: sum of 4 quarters · filed 2021-02-09 |
| 2019-06-30 | -$534.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-07-29 | -$257.00M 10-Q · filed 2020-07-29 | -$234.00M derived: sum of 3 quarters · filed 2021-02-09 | -$304.00M derived: sum of 4 quarters · filed 2021-02-09 |
| 2019-03-31 | $277.00M 10-Q · filed 2020-05-01 | $300.00M derived: sum of 2 quarters · filed 2021-02-09 | $230.00M derived: sum of 3 quarters · filed 2021-02-09 | -$437.00M derived: sum of 4 quarters · filed 2021-02-09 |
| 2018-12-31 | $23.00M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-09 | -$47.00M derived: sum of 2 quarters · filed 2021-02-09 | -$714.00M derived: sum of 3 quarters · filed 2021-02-09 | -$361.00M 10-K · filed 2021-02-09 |
| 2018-09-30 | -$70.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-10-30 | -$737.00M derived: sum of 2 quarters · filed 2019-10-30 | -$384.00M 10-Q · filed 2019-10-30 | $91.00M derived: sum of 4 quarters · filed 2020-02-12 |
| 2018-06-30 | -$667.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-07-31 | -$314.00M 10-Q · filed 2019-07-31 | $161.00M derived: sum of 3 quarters · filed 2020-02-12 | $329.00M derived: sum of 4 quarters · filed 2020-02-12 |
| 2018-03-31 | $353.00M 10-Q · filed 2019-05-01 | $828.00M derived: sum of 2 quarters · filed 2020-02-12 | $996.00M derived: sum of 3 quarters · filed 2020-02-12 | $608.00M derived: sum of 4 quarters · filed 2020-02-12 |
| 2017-12-31 | $475.00M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-12 | $643.00M derived: sum of 2 quarters · filed 2020-02-12 | $255.00M derived: sum of 3 quarters · filed 2020-02-12 | $523.00M 10-K · filed 2020-02-12 |
| 2017-09-30 | $168.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-10-31 | -$220.00M derived: sum of 2 quarters · filed 2018-10-31 | $48.00M 10-Q · filed 2018-10-31 | -$113.00M derived: sum of 4 quarters · filed 2019-02-13 |
| 2017-06-30 | -$388.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-07-27 | -$120.00M 10-Q · filed 2018-07-27 | -$281.00M derived: sum of 3 quarters · filed 2019-02-13 | -$93.00M derived: sum of 4 quarters · filed 2019-02-13 |
| 2017-03-31 | $268.00M 10-Q · filed 2018-04-25 | $107.00M derived: sum of 2 quarters · filed 2019-02-13 | $295.00M derived: sum of 3 quarters · filed 2019-02-13 | -$27.00M derived: sum of 4 quarters · filed 2019-02-13 |
| 2016-12-31 | -$161.00M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-13 | $27.00M derived: sum of 2 quarters · filed 2019-02-13 | -$295.00M derived: sum of 3 quarters · filed 2019-02-13 | -$301.00M 10-K · filed 2019-02-13 |
| 2016-09-30 | $188.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-10-26 | -$134.00M derived: sum of 2 quarters · filed 2017-10-26 | -$140.00M 10-Q · filed 2017-10-26 | -$109.00M derived: sum of 4 quarters · filed 2018-02-13 |
| 2016-06-30 | -$322.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-07-26 | -$328.00M 10-Q · filed 2017-07-26 | -$297.00M derived: sum of 3 quarters · filed 2018-02-13 | -$188.00M derived: sum of 4 quarters · filed 2018-02-13 |
| 2016-03-31 | -$6.00M 10-Q · filed 2017-04-27 | $25.00M derived: sum of 2 quarters · filed 2018-02-13 | $134.00M derived: sum of 3 quarters · filed 2018-02-13 | $418.00M derived: sum of 4 quarters · filed 2018-02-13 |
| 2015-12-31 | $31.00M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-13 | $140.00M derived: sum of 2 quarters · filed 2018-02-13 | $424.00M derived: sum of 3 quarters · filed 2018-02-13 | $509.00M 10-K · filed 2018-02-13 |
| 2015-09-30 | $109.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-10-28 | $393.00M derived: sum of 2 quarters · filed 2016-10-28 | $478.00M 10-Q · filed 2016-10-28 | $699.00M derived: sum of 4 quarters · filed 2017-02-14 |
| 2015-06-30 | $284.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-07-29 | $369.00M 10-Q · filed 2016-07-29 | $590.00M derived: sum of 3 quarters · filed 2017-02-14 | $397.00M derived: sum of 4 quarters · filed 2017-02-14 |
| 2015-03-31 | $85.00M 10-Q · filed 2016-05-02 | $306.00M derived: sum of 2 quarters · filed 2017-02-14 | $113.00M derived: sum of 3 quarters · filed 2017-02-14 | $30.00M derived: sum of 4 quarters · filed 2017-02-14 |
| 2014-12-31 | $221.00M derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-14 | $28.00M derived: sum of 2 quarters · filed 2017-02-14 | -$55.00M derived: sum of 3 quarters · filed 2017-02-14 | -$103.00M 10-K · filed 2017-02-14 |
| 2014-09-30 | -$193.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-02 | -$276.00M derived: sum of 2 quarters · filed 2015-11-02 | -$324.00M 10-Q · filed 2015-11-02 | -$167.00M derived: sum of 4 quarters · filed 2016-10-31 |
| 2014-06-30 | -$83.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-05 | -$131.00M 10-Q · filed 2015-08-05 | $26.00M derived: sum of 3 quarters · filed 2016-10-31 | $135.00M derived: sum of 4 quarters · filed 2016-10-31 |
| 2014-03-31 | -$48.00M 10-Q · filed 2015-04-27 | $109.00M derived: sum of 2 quarters · filed 2016-10-31 | $218.00M derived: sum of 3 quarters · filed 2016-10-31 | $32.00M derived: sum of 4 quarters · filed 2016-10-31 |
| 2013-12-31 | $157.00M derived: 8-K 12 month − 10-Q 9 month · filed 2016-10-31 | $266.00M derived: sum of 2 quarters · filed 2016-10-31 | $80.00M derived: sum of 3 quarters · filed 2016-10-31 | -$326.00M 8-K · filed 2016-10-31 |
| 2013-09-30 | $109.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2014-10-29 | -$77.00M derived: sum of 2 quarters · filed 2014-10-29 | -$483.00M 10-Q · filed 2014-10-29 | -$311.00M derived: sum of 4 quarters · filed 2015-02-19 |
| 2013-06-30 | -$186.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-05 | -$592.00M 10-Q · filed 2014-08-05 | -$420.00M derived: sum of 3 quarters · filed 2015-02-19 | -$448.00M derived: sum of 4 quarters · filed 2015-02-19 |
| 2013-03-31 | -$406.00M 10-Q · filed 2014-04-30 | -$234.00M derived: sum of 2 quarters · filed 2015-02-19 | -$262.00M derived: sum of 3 quarters · filed 2015-02-19 | -$259.00M derived: sum of 4 quarters · filed 2015-02-19 |
| 2012-12-31 | $172.00M derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-19 | $144.00M derived: sum of 2 quarters · filed 2015-02-19 | $147.00M derived: sum of 3 quarters · filed 2015-02-19 | $87.00M 10-K · filed 2015-02-19 |
| 2012-09-30 | -$28.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2013-10-29 | -$25.00M derived: sum of 2 quarters · filed 2013-10-29 | -$85.00M 10-Q · filed 2013-10-29 | $224.00M derived: sum of 4 quarters · filed 2014-02-24 |
| 2012-06-30 | $3.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-06 | -$57.00M 10-Q · filed 2013-08-06 | $252.00M derived: sum of 3 quarters · filed 2014-02-24 | -$102.00M derived: sum of 4 quarters · filed 2014-02-24 |
| 2012-03-31 | -$60.00M 10-Q · filed 2013-05-03 | $249.00M derived: sum of 2 quarters · filed 2014-02-24 | -$105.00M derived: sum of 3 quarters · filed 2014-02-24 | -$88.00M derived: sum of 4 quarters · filed 2014-02-24 |
| 2011-12-31 | $309.00M derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-24 | -$45.00M derived: sum of 2 quarters · filed 2014-02-24 | -$28.00M derived: sum of 3 quarters · filed 2014-02-24 | -$20.00M 10-K · filed 2014-02-24 |
| 2011-09-30 | -$354.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-06 | -$337.00M derived: sum of 2 quarters · filed 2012-11-06 | -$329.00M 10-Q · filed 2012-11-06 | -$183.00M derived: sum of 4 quarters · filed 2013-02-27 |
| 2011-06-30 | $17.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-08 | $25.00M 10-Q · filed 2012-08-08 | $171.00M derived: sum of 3 quarters · filed 2013-02-27 | -$334.00M derived: sum of 4 quarters · filed 2013-02-27 |
| 2011-03-31 | $8.00M 10-Q · filed 2012-05-08 | $154.00M derived: sum of 2 quarters · filed 2013-02-27 | -$351.00M derived: sum of 3 quarters · filed 2013-02-27 | -$459.00M derived: sum of 4 quarters · filed 2013-02-27 |
| 2010-12-31 | $146.00M derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-27 | -$359.00M derived: sum of 2 quarters · filed 2013-02-27 | -$467.00M derived: sum of 3 quarters · filed 2013-02-27 | -$656.00M 10-K · filed 2013-02-27 |
| 2010-09-30 | -$505.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-04 | -$613.00M derived: sum of 2 quarters · filed 2011-11-04 | -$802.00M 10-Q · filed 2011-11-04 | -$977.00M derived: sum of 4 quarters · filed 2012-02-29 |
| 2010-06-30 | -$108.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2011-08-08 | -$297.00M 10-Q · filed 2011-08-08 | -$472.00M derived: sum of 3 quarters · filed 2012-02-29 | -$360.00M derived: sum of 4 quarters · filed 2012-02-29 |
| 2010-03-31 | -$189.00M 10-Q · filed 2011-05-10 | -$364.00M derived: sum of 2 quarters · filed 2012-02-29 | -$252.00M derived: sum of 3 quarters · filed 2012-02-29 | -$507.00M derived: sum of 4 quarters · filed 2012-02-29 |
| 2009-12-31 | -$175.00M derived: 10-K 12 month − 10-Q 9 month · filed 2012-02-29 | -$63.00M derived: sum of 2 quarters · filed 2012-02-29 | -$318.00M derived: sum of 3 quarters · filed 2012-02-29 | -$142.00M 10-K · filed 2012-02-29 |
| 2009-09-30 | $112.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2010-11-08 | -$143.00M derived: sum of 2 quarters · filed 2010-11-08 | $33.00M 10-Q · filed 2010-11-08 | -$41.00M derived: sum of 4 quarters · filed 2011-02-25 |
| 2009-06-30 | -$255.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2010-08-09 | -$79.00M 10-Q · filed 2010-08-09 | -$153.00M derived: sum of 3 quarters · filed 2011-02-25 | -$42.00M derived: sum of 4 quarters · filed 2011-02-25 |
| 2009-03-31 | $176.00M 10-Q · filed 2010-05-07 | $102.00M derived: sum of 2 quarters · filed 2011-02-25 | $213.00M derived: sum of 3 quarters · filed 2011-02-25 | |
| 2008-12-31 | -$74.00M derived: 10-K 12 month − 10-Q 9 month · filed 2011-02-25 | $37.00M derived: sum of 2 quarters · filed 2011-02-25 | $14.00M 10-K · filed 2011-02-25 | |
| 2008-09-30 | $111.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2009-11-06 | $88.00M 10-Q · filed 2009-11-06 | ||
| 2008-06-30 | -$23.00M 10-Q · filed 2009-08-10 | |||
| 2007-12-31 | -$810.00M 10-K · filed 2010-03-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| GILEAD SCIENCES, INC. (GILD) | United States | $185.522B | -48.37 |
| Moderna, Inc. (MRNA) | United States | $77.819B | -8.86 |
| Revolution Medicines, Inc. (RVMD) | United States | $42.805B | -22.69 |
| BIOGEN INC. (BIIB) | United States | $33.427B | 19.60 |
| EXELIXIS, INC. (EXEL) | United States | $14.358B | 16.15 |
| NEUROCRINE BIOSCIENCES INC (NBIX) | United States | $14.131B | 24.25 |
| HALOZYME THERAPEUTICS, INC. (HALO) | United States | $13.083B | 21.59 |
| Twist Bioscience Corp (TWST) | United States | $11.540B | -47.21 |
| BIO-TECHNE Corp (TECH) | United States | $11.379B | 74.68 |
| REPLIGEN CORP (RGEN) | United States | $10.755B | 185.31 |